Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer.

Chromosomal copy number alterations (aneuploidy) define the genomic landscape of most cancer cells, but identification of the oncogenic drivers behind these imbalances remains an unfinished task. In this study, we conducted a systematic analysis of colorectal carcinomas that integrated genomic copy number changes and gene expression profiles. This analysis revealed 44 highly overexpressed genes mapping to localized amplicons on chromosome 13, gains of which occur often in colorectal cancers (CRC). RNA interference (RNAi)-mediated silencing identified eight candidates whose loss-of-function reduced cell viability 20% or more in CRC cell lines. The functional space of the genes NUPL1, LNX2, POLR1D, POMP, SLC7A1, DIS3, KLF5, and GPR180 was established by global expression profiling after RNAi exposure. One candidate, LNX2, not previously known as an oncogene, was involved in regulating NOTCH signaling. Silencing LNX2 reduced NOTCH levels but also downregulated the transcription factor TCF7L2 and markedly reduced WNT signaling. LNX2 overexpression and chromosome 13 amplification therefore constitutively activates the WNT pathway, offering evidence of an aberrant NOTCH-WNT axis in CRC.

[1]  Melissa E. Ko,et al.  CDX2 is an amplified lineage-survival oncogene in colorectal cancer , 2012, Proceedings of the National Academy of Sciences.

[2]  M. Meyerson,et al.  Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. , 2012, Cancer research.

[3]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[4]  T. Ried,et al.  The consequences of chromosomal aneuploidy on the transcriptome of cancer cells. , 2012, Biochimica et biophysica acta.

[5]  M. Vooijs,et al.  Notch: architect, landscaper, and guardian of the intestine. , 2011, Gastroenterology.

[6]  S. Navani,et al.  The human protein atlas , 2011 .

[7]  L. Chin,et al.  Making sense of cancer genomic data. , 2011, Genes & development.

[8]  T. Beißbarth,et al.  A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets , 2011, International journal of cancer.

[9]  M. Taniwaki,et al.  SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma. , 2010, Cancer genetics and cytogenetics.

[10]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[11]  H. Grabsch,et al.  Candidate driver genes in focal chromosomal aberrations of stage II colon cancer , 2010, The Journal of pathology.

[12]  S. Spiegl-Kreinecker,et al.  Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration , 2010, British Journal of Cancer.

[13]  J. Mariadason,et al.  Heterogeneity of Jagged1 expression in human and mouse intestinal tumors: implications for targeting Notch signaling , 2010, Oncogene.

[14]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[15]  T. Ried,et al.  Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer , 2009, Genes, chromosomes & cancer.

[16]  A. Regev,et al.  SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.

[17]  V. Yang,et al.  The role of Krüppel-like factors in the reprogramming of somatic cells to induced pluripotent stem cells. , 2009, Histology and histopathology.

[18]  T. Ried.  Homage to Theodor Boveri (1862–1915): Boveri's theory of cancer as a disease of the chromosomes, and the landscape of genomic imbalances in human carcinomas , 2009, Environmental and molecular mutagenesis.

[19]  Eytan Domany,et al.  Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer , 2009, Proceedings of the National Academy of Sciences.

[20]  N. López-Bigas,et al.  Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer , 2009, Proceedings of the National Academy of Sciences.

[21]  S. Artavanis-Tsakonas,et al.  Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine , 2009, Proceedings of the National Academy of Sciences.

[22]  Pablo Tamayo,et al.  CDK8 is a colorectal cancer oncogene that regulates β-catenin activity , 2008, Nature.

[23]  Lucio Pastore,et al.  Klf5 is involved in self-renewal of mouse embryonic stem cells , 2008, Journal of Cell Science.

[24]  W. Birchmeier,et al.  Wnt signalling and its impact on development and cancer , 2008, Nature Reviews Cancer.

[25]  Yidong Chen,et al.  Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. , 2008, Cancer research.

[26]  Michal A. Kurowski,et al.  Transcriptome Profile of Human Colorectal Adenomas , 2007, Molecular Cancer Research.

[27]  W. Berger,et al.  FGF18 in colorectal tumour cells: autocrine and paracrine effects. , 2007, Carcinogenesis.

[28]  E. Taniguchi,et al.  Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. , 2007, Gastroenterology.

[29]  S. Knuutila,et al.  Specificity, selection and significance of gene amplifications in cancer. , 2007, Seminars in cancer biology.

[30]  Ajay N. Jain,et al.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.

[31]  Eytan Domany,et al.  Relationship of gene expression and chromosomal abnormalities in colorectal cancer. , 2006, Cancer research.

[32]  S. Artavanis-Tsakonas,et al.  Notch signals control the fate of immature progenitor cells in the intestine , 2005, Nature.

[33]  E. Korn,et al.  Chromosome Transfer Induced Aneuploidy Results in Complex Dysregulation of the Cellular Transcriptome in Immortalized and Cancer Cells , 2004, Cancer Research.

[34]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[35]  Yusuke Nakamura,et al.  Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. , 2003, Cancer research.

[36]  D. Albertson,et al.  Chromosome aberrations in solid tumors , 2003, Nature Genetics.

[37]  Hans Clevers,et al.  Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. , 2003, Genes & development.

[38]  Daphne Koller,et al.  Genome-wide discovery of transcriptional modules from DNA sequence and gene expression , 2003, ISMB.

[39]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[40]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Cheryl Wolting,et al.  LNX functions as a RING type E3 ubiquitin ligase that targets the cell fate determinant Numb for ubiquitin‐dependent degradation , 2002, The EMBO journal.

[42]  C. Kurschner,et al.  The Lnx Family Proteins Function as Molecular Scaffolds for Numb Family Proteins , 2001, Molecular and Cellular Neuroscience.

[43]  E. Schröck,et al.  Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype/genotype correlation , 1999, Genes, chromosomes & cancer.

[44]  Thomas Ried,et al.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors , 1996, Genes, chromosomes & cancer.

[45]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[46]  V. Yang,et al.  Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. , 2008, Gastroenterology.

[47]  R. Simon,et al.  Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. , 2007, Cancer research.